Search clinical trials for: Dose-matched Placebo to TS-142
Total 408 results
-
Gilead SciencesCompletedMyocardial Ischemia | Myocardial Perfusion ImagingUnited States, Finland, Israel, Canada, Italy, Singapore, Czech Republic, United Kingdom
-
Stanford UniversityNational Institutes of Health (NIH)RecruitingDiaphragm InjuryUnited States
-
Tonix Pharmaceuticals, Inc.Terminated
-
Assistance Publique Hopitaux De MarseilleCompletedProfessional StressFrance
-
AstraZenecaTerminatedType 2 Diabetes MellitusThailand, Vietnam
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingChronic Obstructive Pulmonary DiseaseChina
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Forest LaboratoriesCompletedMajor Depressive DisorderUnited States
-
University of OxfordNational Health Service, United KingdomUnknownChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Gilead SciencesCompletedHepatitis C VirusUnited States, Puerto Rico
-
Mayo ClinicPfizerCompletedInflammation | Atrial Fibrillation | Arrhythmia | Endothelial DysfunctionUnited States
-
Milton S. Hershey Medical CenterGlaxoSmithKlineCompleted
-
Gilead SciencesWithdrawnTriple-negative Breast Cancer
-
Locus BiosciencesParexelRecruitingUrinary Tract InfectionsUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States, Netherlands, Czechia
-
Merck Sharp & Dohme LLCCompleted
-
Gilead SciencesGalapagos NVCompletedRheumatoid ArthritisUnited States, France, Germany, Spain, Israel, Japan, Korea, Republic of, Belgium, Argentina, Poland, Hungary, United Kingdom, Mexico, Australia, Switzerland
-
AstraZenecaCompletedAlzheimer's DiseasePeru, Poland, Canada, South Africa
-
Gilead SciencesTerminatedCOVID-19United States, Spain, Denmark, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Czechia
-
Organon and CoCompleted
-
Gilead SciencesAstraZenecaTerminatedEnoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart FailureHeart Failure, CongestiveUnited States
-
University Hospital, AngersCompletedPeripheral Arterial Occlusive Disease
-
Laguna Pharmaceuticals, Inc.CompletedAtrial Flutter | Symptomatic Atrial FibrillationIsrael, Russian Federation
-
TheracosCompletedDiabetes Mellitus Type 2United States, Canada
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
CytokineticsRecruitingObstructive Hypertrophic Cardiomyopathy (oHCM)United States, Denmark, Spain, Netherlands, United Kingdom, Germany, France, China, Israel, Italy, Hungary, Canada, Brazil
-
Forest Hills LabNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
MorphoSys AGClinigen Healthcare LtdApproved for marketing
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedMantle-Cell LymphomaFrance, Canada, Spain, United States, Hungary, Korea, Republic of, Greece, Australia, Netherlands, Belgium, United Kingdom, Czechia, Germany, Poland, Italy, Turkey, Ukraine
-
The George InstituteUniversity of Calgary; Berry ConsultantsNot yet recruiting
-
GlaxoSmithKlineWithdrawnPolymyalgia Rheumatica
-
Eisai Inc.CompletedLymphomas | Refractory Solid TumorsUnited States
-
AmgenCompletedHypercholesterolemiaJapan
-
Gilead SciencesGalapagos NVTerminatedNoninfectious UveitisUnited States, Israel, United Kingdom, Germany, Australia, Canada, New Zealand
-
Vanderbilt University Medical CenterNational Institute of Mental Health (NIMH)Recruiting
-
ShireWithdrawnNegative Symptoms of Schizophrenia
-
AmgenCompletedType 2 Diabetes | Hypercholesterolemia | Mixed DyslipidemiaUnited States, Italy, Belgium, Spain, Canada, Poland, Mexico
-
Janssen Research & Development, LLCTerminated
-
Purdue Pharma LPNapp Pharmaceuticals LimitedCompletedChronic Non-malignant PainUnited States, United Kingdom
-
Tonix Pharmaceuticals, Inc.Withdrawn
-
Merck Sharp & Dohme LLCTerminated
-
Solstice NeurosciencesCompleted
-
University of Texas Southwestern Medical CenterNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCCompletedMethamphetamine Use DisorderUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Canada, Finland, France, Germany, Hungary, Italy, Spain, United Kingdom
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, France, Italy, Czechia, Taiwan, Switzerland, Korea, Republic of, Germany, Hong Kong, Netherlands, Australia, Belgium, Canada, Hungary, South Africa, Russian Federation, Spain, United Kingdom, Sweden, Mexico
-
AmgenTIMI Study GroupCompletedHyperlipidemiaUnited States, Canada, Denmark, Czechia, Hungary